CAS博客

Featured Articles

Coronavirus Variants of Concern thumbnail

July 6, 2021

Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? Read this blog and learn about effectiveness of vaccines on Coronavirus variants.

Pfizer Covid Vaccine approved for 12-15 year olds

May 10, 2021

Latest data on the safety and effectiveness of COVID-19 vaccines in children

On May 10, 2021, the U.S. FDA granted an extension of the emergency use authorization for Pfizer/BioNTech’s COVID-19 vaccine for children ages 12-15 based on available safety and efficacy data. Read about the latest data.

performance enhancing drugs CAS blog thumbnail

July 21, 2021

The Science Behind Performance-Enhancing Drugs

Performance enhancing drugs are constantly scrutinized, tracked, and tested for by the International Olympic Committee, US Anti-Doping Agency and World Anti-Doping Agency. This blog will provide details on some common performance enhancing drugs and measures to detect them.

Hero image for Real World Collaboration blog

July 15, 2021

Real World Collaboration: Accelerating Scientific Innovation in an Evolving World

Though we often think of scientific discovery as being driven by competition, going forward, one of the key questions is how we can achieve the optimal balance between collaboration and competition to enhance scientific innovation.

July 6, 2021

Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations

If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? Read this blog and learn about effectiveness of vaccines on Coronavirus variants.

Optimizing AI for improved retrosynthesis predictions

May 28, 2021

Find a better route: Optimizing AI for more novel synthetic predictions

AI and machine learning models aid in retrosynthetic planning, but are limited by the training data they have seen. Read on to learn about ways to generate novel predictions by ensuring your data has the necessary diversity and quality to optimize key synthetic planning initiatives.